ConvaTec Group PLC
LSE:CTEC

Watchlist Manager
ConvaTec Group PLC Logo
ConvaTec Group PLC
LSE:CTEC
Watchlist
Price: 229.2 GBX 0.88% Market Closed
Market Cap: 4.5B GBX

ConvaTec Group PLC
Cost of Revenue

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

ConvaTec Group PLC
Cost of Revenue Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Cost of Revenue CAGR 3Y CAGR 5Y CAGR 10Y
ConvaTec Group PLC
LSE:CTEC
Cost of Revenue
-$1B
CAGR 3-Years
-3%
CAGR 5-Years
-4%
CAGR 10-Years
N/A
Abingdon Health PLC
LSE:ABDX
Cost of Revenue
-ÂŁ4.7m
CAGR 3-Years
10%
CAGR 5-Years
-42%
CAGR 10-Years
N/A
Tristel PLC
LSE:TSTL
Cost of Revenue
-ÂŁ9m
CAGR 3-Years
-13%
CAGR 5-Years
-7%
CAGR 10-Years
-7%
Inspecs Group PLC
LSE:SPEC
Cost of Revenue
-ÂŁ95m
CAGR 3-Years
10%
CAGR 5-Years
-23%
CAGR 10-Years
N/A
Advanced Medical Solutions Group PLC
LSE:AMS
Cost of Revenue
-ÂŁ105.3m
CAGR 3-Years
-29%
CAGR 5-Years
-21%
CAGR 10-Years
-14%
Rua Life Sciences PLC
LSE:RUA
Cost of Revenue
-ÂŁ941k
CAGR 3-Years
-52%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

ConvaTec Group PLC
Glance View

Market Cap
4.7B GBX
Industry
Health Care

ConvaTec Group PLC is a notable player in the realm of medical products and technologies, deftly weaving its narrative within the healthcare industry. Founded in 1978, the company has steadily established itself through strategic expansion and innovation, focusing on improving the lives of patients and enhancing healthcare delivery. The company's core business revolves around four main product categories: Advanced Wound Care, Ostomy Care, Continence and Critical Care, and Infusion Care. Each of these sectors is backed by a robust commitment to research and development, allowing ConvaTec to deliver specialized products that cater to both specific patient needs and broader healthcare system demands. ConvaTec's financial model centers around providing essential, high-quality medical solutions that ultimately support improved patient outcomes. The company garners revenue by partnering with hospitals, healthcare providers, and direct consumer channels, ensuring its products reach where they are most needed. With a global footprint spanning multiple continents, ConvaTec not only distributes its products widely but also adapts its strategy to meet the nuanced requirements of diverse markets. By aligning itself closely with caregivers and leveraging cutting-edge technology, the company maintains a sustainable economic engine through both recurring sales from consumables and long-term relationships with its institutional clients.

CTEC Intrinsic Value
287.43 GBX
Undervaluation 20%
Intrinsic Value
Price

See Also

What is ConvaTec Group PLC's Cost of Revenue?
Cost of Revenue
-1B USD

Based on the financial report for Jun 30, 2025, ConvaTec Group PLC's Cost of Revenue amounts to -1B USD.

What is ConvaTec Group PLC's Cost of Revenue growth rate?
Cost of Revenue CAGR 5Y
-4%

Over the last year, the Cost of Revenue growth was -7%. The average annual Cost of Revenue growth rates for ConvaTec Group PLC have been -3% over the past three years , -4% over the past five years .

Back to Top